» Articles » PMID: 31006548

Leukocyte Adhesion: Reconceptualizing Chemokine Presentation by Glycosaminoglycans

Overview
Journal Trends Immunol
Date 2019 Apr 23
PMID 31006548
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Recruitment of immune cells from the vasculature relies on the presentation of glycosaminoglycan-bound chemokines on the luminal side of vascular endothelial cells. However, the current model of chemokine-glycosaminoglycan interactions, and its implications for receptor interactions, remains poorly developed. We propose a refined 'Chemokine Cloud' model, arguing that chemokines are not presented to leukocytes bound to glycosaminoglycans, but rather, in solution while sequestered within the hydrated glycocalyx. We posit that glycosaminoglycans provide an immobilized chemokine depot maintaining a 'cloud' of 'solution-phase' chemokines within the glycocalyx, and that it is this soluble form of any given chemokine that interacts with leukocyte-bound receptors. Our proposition clarifies certain anomalies associated with the current model of chemokine-glycosaminoglycan interactions, with implications for the design of blockers of chemokine function.

Citing Articles

Location, Location, Location: Spatial Immune-Stroma Crosstalk Drives Pathogenesis in Asthma.

Joulia R, Lloyd C Immunol Rev. 2025; 330(1):e70013.

PMID: 39991870 PMC: 11848993. DOI: 10.1111/imr.70013.


Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?.

Batinac T, Baticic L, Krsek A, Knezevic D, Marcucci E, Sotosek V J Cardiovasc Dev Dis. 2024; 11(12).

PMID: 39728298 PMC: 11677558. DOI: 10.3390/jcdd11120408.


G protein-coupled receptors: a gateway to targeting oncogenic EVs?.

Di Niro L, Linders A, Glynn T, Pegtel D, Siderius M, Crudden C Extracell Vesicles Circ Nucl Acids. 2024; 5(2):233-248.

PMID: 39698539 PMC: 11648488. DOI: 10.20517/evcna.2024.10.


Molecular mechanisms of proteoglycan-mediated semaphorin signaling in axon guidance.

Nourisanami F, Sobol M, Li Z, Horvath M, Kowalska K, Kumar A Proc Natl Acad Sci U S A. 2024; 121(31):e2402755121.

PMID: 39042673 PMC: 11295036. DOI: 10.1073/pnas.2402755121.


The glycosaminoglycan-binding chemokine fragment CXCL9(74-103) reduces inflammation and tissue damage in mouse models of coronavirus infection.

Oliveira V, Queiroz-Junior C, Hoorelbeke D, Santos F, Chaves I, Teixeira M Front Immunol. 2024; 15:1378591.

PMID: 38686377 PMC: 11056509. DOI: 10.3389/fimmu.2024.1378591.